Brazilian Clinical Research Institute Report issue

Academic/Hospital Phase 3 Phase 4

Organization Overview

First Clinical Trial
2012
NCT01448642
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

BCRI | Brazilian Clinical Research Institute

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acute Coronary Syndrome (Phase 4)

Aneurysm (Phase 3)

Aortic Aneurysm (Phase 3)

Coronavirus Infections (Phase 4)

Infarction (Phase 3)

Myocardial Infarction (Phase 3)

Peripheral Arterial Disease (Phase 3)

Peripheral Vascular Diseases (Phase 3)

Pneumonia (Phase 3)

Severe Acute Respiratory Syndrome (Phase 4)

Syndrome (Phase 4)

Vascular Diseases (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 7
  • # of Trial APIs: 8